Recombinant Clostridium botulinum GTPase Era (era)

What is the molecular structure and domain organization of C. botulinum GTPase Era?

Clostridium botulinum GTPase Era is a relatively small protein (approximately 300-350 amino acids, ~35 kDa) consisting of two globular domains connected by an unstructured linker. The protein architecture includes:

• An N-terminal GTPase domain (~170 amino acids) with a characteristic fold featuring a 6-stranded β-sheet surrounded by 5 α-helices in a highly conserved alternating pattern

• A C-terminal KH domain that confers RNA-binding activity

• A conserved linker region between the domains that maintains precise structural coordination

The GTPase domain contains five diagnostic motifs (G1-G5) involved in GTP binding and hydrolysis. The β-strands in this domain are parallel, except for β2, which is uniquely antiparallel as observed in all TRAFAC GTPases .

How does the GTPase activity of Era function as a molecular switch?

Era functions as a molecular switch through a GTP-dependent conformational change mechanism:

• In the GTP-bound "ON-state," Era's KH domain is oriented to allow RNA access to the binding site

• In the GDP-bound or apo "OFF-state," a negatively charged helix (αD) partially blocks access to the RNA-binding groove

• GTP hydrolysis triggers conformation switching, coupling chemical reactions to mechanical movement

• The switching mechanism times Era's intervention in ribosome biogenesis

• Era has poor intrinsic GTPase activity as it lacks a critical glutamine residue in switch II (making it a HAS-GTPase - Hydrophobic Amino Acid Substituted)

• RNA binding, especially to 16S rRNA, stimulates Era's GTPase activity by approximately an order of magnitude

This switching behavior allows Era to cycle between states, driving forward ribosome assembly processes .

What experimental methods are used to express and purify recombinant C. botulinum GTPase Era?

Recombinant C. botulinum GTPase Era can be efficiently produced using the following methodology:

Expression System:

• Escherichia coli is the preferred expression host

• Expression vectors containing a tag sequence (commonly His-tag) facilitate purification

• Induction with IPTG at optimal temperature (typically 18-25°C) maximizes soluble protein yield

Purification Protocol:

• Harvest cells by centrifugation and lyse using either sonication or mechanical disruption

• Clarify the lysate by high-speed centrifugation (typically 20,000 × g)

• Apply to an affinity chromatography column (Ni-NTA for His-tagged protein)

• Wash extensively to remove non-specifically bound proteins

• Elute with increasing concentrations of imidazole

• Perform size exclusion chromatography to obtain highly pure protein

• Concentrate to 0.1-1.0 mg/mL in a suitable buffer

• Add 5-50% glycerol for long-term storage at -20°C/-80°C

The recombinant protein typically achieves >85% purity as assessed by SDS-PAGE .

How does Era interact with the small ribosomal subunit during assembly?

Era plays a critical role in the early stages of small subunit (SSU) biogenesis through specific molecular interactions:

• Era binds to the 3' end of 16S rRNA, specifically to helix 45 (h45) and the single-stranded terminal sequence

• The KH domain recognizes the conserved GAUCA sequence at the 3' end of 16S rRNA via its GxxG motif

• While in its GTP-bound state, Era interacts with the platform region of the nascent 30S subunit

• Cryo-EM studies show that the GTPase domain of Era can also bind to helix 26 of the 16S rRNA and the S18 ribosomal protein

• Era acts as a checkpoint, preventing premature association of the 30S and 50S subunits by occupying key intersubunit bridge sites

• Era's binding to the SSU establishes proper shaping of the platform region, which is critical for subsequent translation

The timing of Era's action is governed by its GTPase cycle, with GTP hydrolysis likely triggering its release from the maturing ribosome .

What protein interaction network does Era form during ribosome biogenesis?

Era forms an extensive interaction network that coordinates various aspects of ribosome assembly:

Era acts as a hub protein that guides rRNA/ribosome maturation enzymes to their substrates. In Clostridium botulinum and some other bacteria, Era is frequently found in genomic proximity to or even fused with YbeY, further emphasizing their functional relationship in ribosomal assembly .

How does the stringent response alarmone (p)ppGpp regulate Era activity?

The stringent response alarmone (p)ppGpp regulates Era activity through multiple mechanisms:

• (p)ppGpp directly binds to Era with high affinity (K_d of approximately 3.1 ± 0.4 μM)

• This binding inhibits Era's GTPase activity, preventing its normal function in ribosome assembly

• Rel_Sau, a (p)ppGpp synthetase, directly interacts with Era and positively impacts its GTPase activity

• The increased GTPase activity caused by Rel_Sau could potentially promote premature dissociation of Era from immature 30S subunits

• Era has a higher affinity for ppGpp than GTP, which could inhibit Era's association with ribosomes

• The stringent response also inhibits the helicase activity of CshA, an Era interaction partner

• Activation of the stringent response leads to increased rRNA processing defects, particularly at lower temperatures (25°C)

These regulatory mechanisms link ribosome assembly to the broader stress response network, allowing bacteria to coordinate protein synthesis with environmental conditions .

What phenotypic effects result from Era mutations or deletion in different bacterial species?

Mutations or deletion of Era result in diverse phenotypic effects across bacterial species:

• In many bacteria like E. coli, Era is essential, and its deletion is lethal

• In Staphylococcus aureus, Era is not essential but is important for 30S ribosomal subunit assembly

• Conservative mutations in the G1 and G2 motifs (e.g., K21R in E. coli) can be lethal

• Milder mutations that don't fully disrupt GTPase activity produce viable but severe phenotypes including:

  • Heat and cold sensitivity

  • Cell filamentation

  • Significant growth delay

  • Inability to use certain carbon sources

• The N236I mutation in human ERAL1 (Era homolog) causes Perrault syndrome (sensorineural deafness and ovarian dysgenesis)

• Removal of the KH domain or mutations in its RNA-binding motifs result in severe loss-of-function phenotypes

• The Era(T99I) mutation in E. coli can partially suppress phenotypes caused by deletion of YbeY, improving 16S rRNA processing and ribosome assembly at 37°C

• Overexpression of the KH domain alone is toxic in various bacteria, indicating the importance of coordinated function between both domains

These phenotypes highlight Era's critical role in ribosome biogenesis and broader cellular physiology .

What techniques are effective for analyzing GTPase activity of recombinant Era protein?

Several robust techniques can be employed to analyze the GTPase activity of recombinant Era:

Colorimetric Phosphate Detection Assay:

• Incubate Era protein (0.1-1 μM) with GTP (50-200 μM) in reaction buffer (typically containing Mg²⁺)

• At timed intervals, stop reactions with malachite green or molybdate reagent

• Measure inorganic phosphate release colorimetrically

• Calculate initial rates to determine kinetic parameters (K_m, k_cat)

Radioactive GTP Hydrolysis Assay:

• Incubate Era protein with [γ-³²P]GTP

• Separate released ³²P_i from GTP by thin-layer chromatography

• Quantify radioactivity using phosphorimager analysis

Effects of RNA and Ribosomes:

• Include 16S rRNA, helix 45 RNA fragments, or 30S/70S ribosomes in reactions to assess stimulatory effects

• Add increasing concentrations of (p)ppGpp to measure inhibitory effects

Nucleotide Binding Analysis:

• Use techniques like differential radial capillary action of ligand assay (DRaCALA) to measure binding affinities of different nucleotides (GTP, GDP, ppGpp) to Era

These methods can be adapted to study how Era variants, interacting proteins (like Rel_Sau), or environmental conditions affect GTPase activity .

How can researchers study Era-dependent ribosome assembly defects?

To study Era-dependent ribosome assembly defects, researchers can employ the following methodological approaches:

Ribosomal Profiling:

• Grow bacterial cultures with Era mutations or under Era depletion conditions

• Prepare cell lysates carefully to preserve ribosome integrity

• Separate ribosomal components on 10-40% sucrose gradients by ultracentrifugation

• Monitor absorbance at 254 nm to generate profiles showing free 30S, 50S, 70S, and polysomes

• Compare profiles to identify assembly defects in specific subunits or mature ribosomes

RNA Analysis:

• Extract total RNA using hot-phenol or commercial kits

• Analyze 16S rRNA processing by northern blotting or primer extension

• Map precise 5' and 3' ends of 16S rRNA using primer extension or RNA-seq

• Perform qRT-PCR to quantify precursor and mature rRNA species

Protein-RNA Interaction Analysis:

• Perform in vitro binding assays with purified Era and 16S rRNA

• Use techniques like electrophoretic mobility shift assay (EMSA) or filter binding assays

• Apply RNA footprinting to map Era binding sites on 16S rRNA

• Employ cryo-EM to visualize Era-bound ribosomal assembly intermediates

Suppressor Analysis:

• Generate Era variants (e.g., Era(T99I)) to study how they affect ribosome assembly

• Analyze how these variants suppress defects caused by deletion of other assembly factors

• Examine changes in ribosome composition using mass spectrometry to identify proteins that associate with Era-bound ribosomes

These approaches provide complementary data on Era's role in ribosome assembly .

What methods can identify and characterize protein-protein interactions involving Era in C. botulinum?

Multiple complementary techniques can be employed to study Era's protein-protein interactions:

Affinity Pulldown Assays:

• Express recombinant Era with affinity tags (His, GST, etc.)

• Immobilize on appropriate resin and incubate with cell lysates

• Wash extensively to remove non-specific binding

• Elute and analyze interacting proteins by SDS-PAGE and mass spectrometry

• Confirm specificity by comparing to appropriate controls

Bacterial Two-Hybrid (B2H) Screening:

• Create fusion constructs of Era with B2H domains

• Screen against genomic libraries or specific candidate proteins

• Positive interactions reconstitute reporter gene activity

• Validate positive hits using alternative techniques

Split Luciferase Complementation Assay:

• Fuse Era and candidate partners to complementary luciferase fragments

• Co-express in appropriate host cells

• Measure reconstituted luciferase activity as indicator of protein interaction

• This technique confirmed interactions between Era, CshA, and Rel_Sau

Domain Mapping:

• Create deletion constructs expressing individual Era domains

• Identify minimal regions required for specific protein interactions

• For example, the GTPase domain of Era is sufficient for interaction with Rel_Sau

Co-immunoprecipitation from Native Sources:

• Generate antibodies against Era or use tagged versions

• Perform immunoprecipitation from C. botulinum lysates

• Identify co-precipitating proteins by mass spectrometry

These approaches have successfully identified Era's interactions with YbeY, CshA, Rel_Sau, and other proteins involved in ribosome assembly .

What are the unique characteristics of C. botulinum Era compared to Era proteins from other bacterial species?

Comparative analysis reveals several distinctive features of C. botulinum Era:

Sequence Characteristics:

• C. botulinum Era protein (strain Hall/ATCC 3502) consists of 296 amino acids

• Contains the canonical GTPase and KH domains connected by a conserved linker

• The protein sequence includes five GTPase signature motifs (G1-G5) required for nucleotide binding and hydrolysis

Structural Features:

• The GTPase domain contains the characteristic fold with alternating β-strands and α-helices

• The KH domain maintains the RNA-binding motif essential for 16S rRNA recognition

• Like other Era proteins, it likely functions through a conserved GTP-dependent conformational switching mechanism

Genomic Context:

• In some Clostridia, Era is found fused with YbeY, an endoribonuclease involved in 16S rRNA processing

• This fusion architecture is one of the few instances where Era is naturally found linked to another protein domain

• The YbeY-Era fusion is found in several members of the Clostridia group and some Selenomonadales

Expression and Localization:

• As in other bacteria, C. botulinum Era likely associates with the 30S ribosomal subunit during assembly

• The protein likely participates in the maturation of the platform region of the small subunit

The YbeY-Era fusion suggests a particularly strong functional relationship between these two ribosome biogenesis factors in Clostridia, potentially representing an evolutionary adaptation for coordinated rRNA processing in these bacteria .

What are the challenges and safety considerations when working with recombinant proteins from C. botulinum?

Working with recombinant proteins from C. botulinum presents several important challenges and safety considerations:

Biosafety Challenges:

• C. botulinum is a highly pathogenic organism that produces botulinum neurotoxin (BoNT), the most potent toxin known

• Native C. botulinum requires high levels of biocontainment (BSL-3)

• Spore-forming ability increases contamination risks in laboratory settings

Advantages of Recombinant Expression:

• Expression of C. botulinum proteins in E. coli eliminates the need to culture the pathogenic organism

• Recombinant expression overcomes the challenge of slow growth and anaerobic culture requirements of C. botulinum

• Purification from native C. botulinum is time-consuming (11+ days) and shows significant batch-to-batch variation

Experimental Considerations:

• Recombinant Era can be expressed in E. coli and purified using standard methods

• Proper folding and activity should be verified through functional assays

• When studying Era's interactions with C. botulinum-specific partners, these must also be expressed recombinantly

• Codon optimization may be necessary due to differences in codon usage between C. botulinum and E. coli

Regulatory Issues:

• Work with certain C. botulinum genes may require institutional biosafety committee approval

• Shipping and receiving recombinant C. botulinum proteins may be subject to regulatory oversight

• Documentation of safety measures and containment procedures is essential

Recombinant expression provides a safer alternative to working with native C. botulinum while still enabling detailed biochemical and structural studies of proteins like Era .

How can structural studies of Era inform the development of antimicrobial strategies against C. botulinum?

Structural analysis of Era presents several opportunities for antimicrobial development:

• Era is highly conserved and essential in many bacteria but absent in humans, making it an attractive target for selective antimicrobials

• The GTPase domain contains unique structural features that could be targeted by small molecule inhibitors

• Crystal structures of Era show distinct conformational states that could be locked by appropriate inhibitors

• Understanding the GTP binding and hydrolysis mechanisms provides opportunities for designing non-hydrolyzable GTP analogs that might inhibit Era function

• The interaction interface between Era and 16S rRNA presents another potential target for disruption

• Mutations that affect Era function (like T99I) provide insights into regions critical for activity that could be targeted

• The specialized role of Era in cold adaptation suggests that inhibitors might be particularly effective under certain environmental conditions

Given C. botulinum's significant public health importance and the limited treatment options for botulism, Era represents a promising target for new antimicrobial strategies .

What future research directions might advance our understanding of Era's role in bacterial ribosomes?

Several promising research directions could significantly enhance our understanding of Era's functions:

Structural Biology Approaches:

• High-resolution cryo-EM structures of Era bound to ribosome assembly intermediates from C. botulinum

• Time-resolved structural studies to capture the dynamic process of Era-mediated ribosome assembly

• Structural analysis of Era in complex with its protein partners like YbeY and CshA

Functional Genomics:

• CRISPR interference studies to investigate the effects of Era depletion in C. botulinum

• Global transcriptomic and proteomic analysis following Era manipulation

• Suppressor screens to identify genetic interactions

Biochemical Investigations:

• Reconstitution of complete ribosome assembly pathways involving Era in vitro

• Detailed analysis of how Era coordinates with other assembly factors temporally

• Investigation of post-translational modifications that might regulate Era function

Translational Research:

• Development and screening of small molecule inhibitors targeting Era

• Evaluation of Era inhibitors against C. botulinum and other pathogenic bacteria

• Investigation of Era as a potential vaccine target

Evolutionary Studies:

• Comparative analysis of Era function across diverse bacterial species

• Investigation of the evolutionary significance of Era-YbeY fusions in certain Clostridia

These research directions would provide a more comprehensive understanding of Era's multifaceted roles in bacterial physiology and potentially lead to new strategies for controlling C. botulinum and other pathogens .